WebSep 16, 2024 · Neulasta Onpro kit is provided in a carton containing one sterile prefilled syringe and one sterile on-body injector (OBI) for Neulasta (NDC 55513-192-01). The Neulasta injection single-dose prefilled syringe contains 0.64 mL of a clear, colorless solution that delivers 6 mg/0.6 mL of pegfilgrastim when used with the OBI for Neulasta. WebJul 25, 2024 · The Neulasta on-body injector starts delivering the Neulasta dose 27 hours after the Neulasta on-body injector has been applied to the skin. When the Neulasta on-body injector is delivering the dose the green light will be rapidly flashing, the delivery process takes about 45 minutes to complete.
Neulasta injection: Side effects, dosage, uses, and more
WebJan 1, 2024 · *Note: Effective 01/01/2024 providers are instructed to use 96377 for the on-body application injector for Neulasta® Onpro Kit. **When billing filgrastim (HCPCS code J1442, Q5101 or Q5110), append the JA modifier for the IV formulation or the JB modifier for the subcutaneous formulation. WebApr 4, 2024 · The Neulasta brand of pegfilgrastim is a prescription medication used to: Decrease the risk of infection, demonstrated by the presence of febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs that are likely to cause febrile neutropenia. four wands reversed
Neulasta: Package Insert - Drugs.com
WebFeb 1, 2024 · This medicine may be given in 2 ways: a single prefilled syringe for manual use or for use with the On-body Injector for Neulasta® use. This medicine comes with patient instructions. Read and follow these instructions carefully. Ask your doctor if you have any questions about: How to prepare the injection. The proper use of disposable syringes. WebKeep the on-body injector for Neulasta at least 4 inches away from electrical equipment such as cell phones, cordless telephones, microwaves and other common appliances. If the on-body injector for Neulasta is too close to electrical equipment, it may not work correctly and can lead to a missed or incomplete dose of Neulasta. ... WebNeulasta is a leukocyte growth factor indicated to . discontinue Neulasta in patients with serious allergic reactions. (5.3) • Decrease the incidence of infection, as manifested by febrile • The on-body injector for Neulasta uses acrylic adhesive. For patients neutropenia, in patients with non -myeloid malignancies receiving four wands tarot